Enfermedad por virus sincitial respiratorio en pediatría más allá del compromiso respiratorio
Respiratory syncytial virus disease in children: beyond respiratory involvement
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Mostrar biografía de los autores
Introducción: el virus sincitial respiratorio (VSR) suele asociarse con la enfermedad respiratoria en la población pediátrica, sin embargo se han documentado múltiples manifestaciones extrapulmonares, en especial neurológicas. Objetivo: presentar un panorama de los reportes en la literatura indexada sobre el compromiso neurológico en la infección por VSR. Materiales y Métodos: revisión sistemática exploratoria formal de la literatura en las bases de datos Pubmed y SCOPUS, que incluyó estudios primarios y secundarios hasta el 17 de julio 2022, publicadas en inglés, español y francés. Resultados: se consideraron 30 publicaciones que describían la experiencia en 1.681 pacientes con una edad mediana de 17 meses y mayor compromiso del sexo masculino (64.59%), en el marco de la enfermedad respiratoria grave por VSR. Las convulsiones y la apnea central aparecieron como principales manifestaciones, ya sea por invasión viral e inflamación secundaria del sistema nervioso central (SNC) o por la compensación derivada de los ajustes neuroendocrinos ante el daño respiratorio severo. Las secuelas a largo plazo incluyeron retraso en el desarrollo y discapacidad cognitiva. Conclusión: el síndrome por infección respiratoria grave por VSR puede ocurrir con compromiso neurológico, posiblemente derivado de la acción directa del virus a nivel del SNC o de los efectos del proceso adaptativo. Estos dos mecanismos deben considerarse en presencia de enfermedad respiratoria grave por VSR que cursen con deterioro neurológico, para una correcta aproximación diagnóstica y manejo oportuno, con el fin de disminuir el riesgo de secuelas significativas.
Visitas del artículo 1743 | Visitas PDF 1274
Descargas
- Griffiths C, Drews SJ, Marchant DJ. New options for prevention and treatment. Clin Microbiol Rev. 2017;30(1):277–319. https://doi.org/10.1128/CMR.00010-16
- Yu J, Liu C, Xiao Y, Xiang Z, Zhou H, Chen L, et al. Respiratory syncytial virus seasonality, Beijing, China, 2007-2015. Emerg Infect Dis. 2019;25(6):1127–35. https://doi.org/10.3201/eid2506.180532
- Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol. 2017;52(4):556–69. https://doi.org/10.1002/ppul.23570
- Ospina Martíne ML, Prieto Alvarado FE, Walteros D, Quijada Bonilla H. Semana epidemiológica 40 - 29 de sep. al 5 de octubre de 2019. Infección Respiratoria Aguda. Colombia: Instituto Nacional de Salud. Boletín Epidemiológico Semanal; 2019. https://doi.org/10.33610/23576189.2019.40
- Jain H, Schweitzer JW, Justice NA. Respiratory Syncytial Virus Infection. StatPearls; 2021.
- Bohmwald K, Espinoza JA, Rey-Jurado E, et al. Human Respiratory Syncytial Virus: Infection and Pathology. Semin Respir Crit Care Med. 2016;37(4):522-537. https://doi.org/10.1055/s-0036-1584799
- Mammas IN, Drysdale SB, Rath B, Theodoridou M, Papaioannou G, Papatheodoropoulou A, et al. Update on current views and advances on RSV infection (Review). Int J Mol Med. 2020;46(2):509-520. https://doi.org/10.3892/ijmm.2020.4641.
- Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-1555. https://doi.org/10.1016/S0140-6736(10)60206-1
- Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol.2005;8(1):19–32. https://doi.org/10.1080/1364557032000119616
- Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.22. https://doi.org/10.1186/1748-5908-5-69
- Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https://doi.org/10.1186/s13643-016-0384-4
- Grudniewicz A, Nelson M, Kuluski K, et al. Treatment goal setting for complex patients: protocol for a scoping review. BMJ Open. 2016;6(5):e011869.26. https://doi.org/10.1136/bmjopen-2016-011869
- Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.23. https://doi.org/10.7326/M18-0850
- Hirayama K, Sakazaki H, Murakami S, et al. Sequential MRI, SPECT and PET in respiratory syncytial virus encephalitis. Pediatr Radiol. 1999;29(4):282-286. https://doi.org/10.1007/s002470050589
- Picone S, Mondì V, Di Palma F, Martini L, Paolillo P. Neonatal Encephalopathy and SIADH during RSV Infection. Am J Perinatol. 2019;36(S02):S106-S109. https://doi.org/10.1055/s-0039-1692132
- Sugimoto M, Morichi S, Kashiwagi Y, et al. A case of respiratory syncytial virus-associated encephalopathy in which the virus was detected in cerebrospinal fluid and intratracheal aspiration despite negative rapid test results. J Infect Chemother. 2020;26(4):393-396. https://doi.org/10.1016/j.jiac.2019.11.008
- Rantala H, Uhari M, Tuokko H. Viral infections and recurrences of febrile convulsions. J Pediatr. 1990;116(2):195-199. https://doi.org/10.1016/s0022-3476(05)82874-4
- Kho N, Kerrigan JF, Tong T, Browne R, Knilans J. Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study. J Child Neurol. 2004;19(11):859-864. https://doi.org/10.1177/08830738040190110301
- Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005;32(5):307-310. https://doi.org/10.1016/j.pediatrneurol.2005.01.010
- Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures. Pediatr Neurol. 2006;35(3):165-172. https://doi.org/10.1016/j.pediatrneurol.2006.06.004
- Kawashima H, Ioi H, Ushio M, Yamanaka G, Matsumoto S, Nakayama T. Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand J Infect Dis. 2009;41(3):228-231. https://doi.org/10.1080/00365540802669543
- Ong SCL, Nur Azidawati AH, Liew YH, Anita S. Acute necrotising encephalopathy of childhood: A review of two cases. Med J Malaysia. 2017;72(5):311-313.
- Miyama S, Goto T. Afebrile seizures associated with respiratory syncytial virus infection: a situation-related seizure disorder in early infancy. Pediatr Int. 2011;53(1):113-115. https://doi.org/10.1111/j.1442-200X.2010.03188.x.
- Cha T, Choi YJ, Oh JW, et al. Respiratory syncytial virus-associated seizures in Korean children, 2011-2016. Korean J Pediatr. 2019;62(4):131-137. https://doi.org/10.3345/kjp.2018.07066
- Miyamoto K, Fujisawa M, Hozumi H, et al. Systemic inflammatory response syndrome and prolonged hypoperfusion lesions in an infant with respiratory syncytial virus encephalopathy. J Infect Chemother. 2013;19(5):978-982. https://doi.org/10.1007/s10156-013-0558-0
- Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55. https://doi.org/10.1016/S0140-6736(10)60206-1
- Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care. 2006;10(4):R107. https://doi.org/10.1186/cc4984
- Soung A, Klein RS. Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes. Trends Mol Med. 2018;24(11):950–62. https://doi.org/10.1016/j.molmed.2018.09.001
- Hoyer C, Eisele P, Ebert AD, Schneider S, Gass A, Fatar M, et al. Blood-CSF-barrier dysfunction is a marker for encephalitic involvement in patients with aseptic meningitis/meningoencephalitis. J Clin Virol. 2016;84:82–6. https://doi.org/10.1016/j.jcv.2016.10.006
- El-Bitar MK, Boustany RM. Common causes of uncommon seizures. Pediatr Neurol. 2009;41(2):83-87. https://doi.org/10.1016/j.pediatrneurol.2009.04.011
- Bohmwald K, Espinoza JA, González PA, Bueno SM, Riedel CA, Kalergis AM. Central nervous system alterations caused by infection with the human respiratory syncytial virus. Rev Med Virol. 2014;24(6):407-419. https://doi.org/10.1002/rmv.1813
- Bohmwald K, Espinoza JA, Becerra D, et al. Inflammatory damage on respiratory and nervous systems due to hRSV infection. Curr Opin Immunol. 2015;36:14-21. https://doi.org/10.1016/j.coi.2015.05.003
- Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018;12:386. https://doi.org/10.3389/fncel.2018.00386
- Robinson CP, Busl KM. Neurologic Manifestations of Severe Respiratory Viral Contagions. Crit Care Explor. 2020;2(4):e0107. https://doi.org/10.1097/CCE.0000000000000107
- Erez DL, Yarden-Bilavsky H, Mendelson E, et al. Apnea induced by respiratory syncytial virus infection is not associated with viral invasion of the central nervous system. Pediatr Infect Dis J. 2014;33(8):880-881. https://doi.org/10.1097/INF.0000000000000311
- Venkatesan A, Murphy OC. Viral Encephalitis. Neurol Clin. 2018;36(4):705–24. https://doi.org/10.1016/j.ncl.2018.07.001
- Ferolla FM, Soffe J, Mistchenko A, Contrini MM, López EL. Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection. Arch Argent Pediatr. 2019;117(4):216-223 https://doi.org/10.5546/aap.2019.eng.216
- Domachowske JB, Anderson EJ, Goldstein M. The Future of Respiratory Syncytial Virus Disease Prevention and Treatment. Infect Dis Ther. 2021;10(Suppl 1):47–60. https://doi.org/10.1007/s40121-020-00383-6